Titan Medical to Be Delisted From Nasdaq

Dow Jones

Mar 09, 2023

By Robb M. Stewart

Titan Medical Inc. said Thursday that Nasdaq has decided to delist its shares, adding that its shares will continue to trade on the Toronto Stock Exchange and it expects to be eligible for quotation on the OTC Markets.

The Canadian medical-device company said it received a decision from the Nasdaq hearings panel advising it would be delisted from the start of business Friday.

Nasdaq's decision comes after a hearing earlier this year between Titan Medical and Nasdaq following the stock exchange's earlier decision to push for a delisting after the company failed to regain compliance with a minimum bid-price requirement.

In premarket trading, the Nasdaq-listed shares were 18% lower after ending the previous session at 19 cents, down 71% year-to-date. The Toronto-traded shares last closed at C$0.26, down 71% so far this year.

Last month, Toronto-based Titan said it had laid off a number of its senior managers as it looked to cut costs and planned to sell all or some of the company's assets. The decision came after a strategic review process launched last November failed to attract a suitor interested in pursuing a deal with the company.

Write to Robb M. Stewart at robb.stewart@wsj.com

(END) Dow Jones Newswires

March 09, 2023 07:52 ET (12:52 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2318443267"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2318443267\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2318443267?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-03-09 20:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2318443267","market":"us","top_or_hot":-1,"title":"Titan Medical to Be Delisted From Nasdaq","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Robb M. Stewart \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/TMDI\">Titan Medical Inc.</a> said Thursday that Nasdaq has decided to delist its shares, adding that its shares will continue to trade on the Toronto Stock Exchange and it expects to be eligible for quotation on the OTC Markets. \n</p>\n<p>\n  The Canadian medical-device company said it received a decision from the Nasdaq hearings panel advising it would be delisted from the start of business Friday. \n</p>\n<p>\n  Nasdaq's decision comes after a hearing earlier this year between Titan Medical and Nasdaq following the stock exchange's earlier decision to push for a delisting after the company failed to regain compliance with a minimum bid-price requirement. \n</p>\n<p>\n  In premarket trading, the Nasdaq-listed shares were 18% lower after ending the previous session at 19 cents, down 71% year-to-date. The Toronto-traded shares last closed at C$0.26, down 71% so far this year. \n</p>\n<p>\n  Last month, Toronto-based Titan said it had laid off a number of its senior managers as it looked to cut costs and planned to sell all or some of the company's assets. The decision came after a strategic review process launched last November failed to attract a suitor interested in pursuing a deal with the company. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Robb M. Stewart at robb.stewart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 09, 2023 07:52 ET (12:52 GMT)\n</p>\n<p>\n  Copyright (c) 2023 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Titan Medical to Be Delisted From Nasdaq</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTitan Medical to Be Delisted From Nasdaq\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2023-03-09 20:52</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Robb M. Stewart \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/TMDI\">Titan Medical Inc.</a> said Thursday that Nasdaq has decided to delist its shares, adding that its shares will continue to trade on the Toronto Stock Exchange and it expects to be eligible for quotation on the OTC Markets. \n</p>\n<p>\n  The Canadian medical-device company said it received a decision from the Nasdaq hearings panel advising it would be delisted from the start of business Friday. \n</p>\n<p>\n  Nasdaq's decision comes after a hearing earlier this year between Titan Medical and Nasdaq following the stock exchange's earlier decision to push for a delisting after the company failed to regain compliance with a minimum bid-price requirement. \n</p>\n<p>\n  In premarket trading, the Nasdaq-listed shares were 18% lower after ending the previous session at 19 cents, down 71% year-to-date. The Toronto-traded shares last closed at C$0.26, down 71% so far this year. \n</p>\n<p>\n  Last month, Toronto-based Titan said it had laid off a number of its senior managers as it looked to cut costs and planned to sell all or some of the company's assets. The decision came after a strategic review process launched last November failed to attract a suitor interested in pursuing a deal with the company. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Robb M. Stewart at robb.stewart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 09, 2023 07:52 ET (12:52 GMT)\n</p>\n<p>\n  Copyright (c) 2023 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4152","symbol_name":"农用农业机械","start_time":0,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2318443267","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2318443267","pubTimestamp":1678366320,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"By Robb M. Stewart \n\n\n \n\n\nTitan Medical Inc. said Thursday that Nasdaq has decided to delist its sha","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4152":"农用农业机械","BK4082":"医疗保健设备","TMDIF":"Titan Medical Inc.","TWI":"泰坦国际"},"translate_title":"泰坦医疗将从纳斯达克退市","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TMDIF":0.9,"TMDI":0.9,"TWI":1},"content_text":"By Robb M. Stewart \n\n\n \n\n\nTitan Medical Inc. said Thursday that Nasdaq has decided to delist its shares, adding that its shares will continue to trade on the Toronto Stock Exchange and it expects to be eligible for quotation on the OTC Markets. \n\n\n  The Canadian medical-device company said it received a decision from the Nasdaq hearings panel advising it would be delisted from the start of business Friday. \n\n\n  Nasdaq's decision comes after a hearing earlier this year between Titan Medical and Nasdaq following the stock exchange's earlier decision to push for a delisting after the company failed to regain compliance with a minimum bid-price requirement. \n\n\n  In premarket trading, the Nasdaq-listed shares were 18% lower after ending the previous session at 19 cents, down 71% year-to-date. The Toronto-traded shares last closed at C$0.26, down 71% so far this year. \n\n\n  Last month, Toronto-based Titan said it had laid off a number of its senior managers as it looked to cut costs and planned to sell all or some of the company's assets. The decision came after a strategic review process launched last November failed to attract a suitor interested in pursuing a deal with the company. \n\n\n \n\n\n  Write to Robb M. Stewart at robb.stewart@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 09, 2023 07:52 ET (12:52 GMT)\n\n\n  Copyright (c) 2023 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}